![Christopher Lai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Lai
Vorstandsvorsitzender bei
METIS TECHBIO CO., LTD.
Vermögen: 289 Mio $ am 30.06.2026
Profil
Dr. Christopher Lai is a Chairman & Chief Executive Officer at Metis TechBio Co., Ltd., a General Manager & Executive Director at Metis Pharmaceuticals and a Chief Executive Officer at METiS Therapeutics, Inc. He is on the Board of Directors at Metis Pharmaceuticals.
Dr. Lai was previously employed as a Chief Technology Officer by AquaFresco, Inc.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 10.06.2026 | 111’166’572 ( 10.26% ) | 218 Mio $ | 30.06.2026 | |
METIS TECHBIO CO., LTD. 36.55% | 13.05.2026 | 36’400’278 ( 36.55% ) | 71 Mio $ | 30.06.2026 |
Aktive Positionen von Christopher Lai
| Unternehmen | Position | Beginn |
|---|---|---|
| METIS TECHBIO CO., LTD. | Vorstandsvorsitzender | 10.01.2020 |
METiS Therapeutics, Inc.
 METiS Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for patients with diseases | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Christopher Lai
| Unternehmen | Position | Ende |
|---|---|---|
AquaFresco, Inc.
 AquaFresco, Inc. Industrial MachineryProducer Manufacturing Designs and develops water recycling technology | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
14
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
AquaFresco, Inc.
AquaFresco, Inc. Industrial MachineryProducer Manufacturing Designs and develops water recycling technology | Producer Manufacturing |
METiS Therapeutics, Inc.
METiS Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for patients with diseases | Health Technology |
Hangzhou Jitai Pharmaceutical Technology Co. Ltd.
 Hangzhou Jitai Pharmaceutical Technology Co. Ltd. Chemicals: Major DiversifiedProcess Industries Operates as an investment holding company whose subsidiaries provides AI based nanomaterials delivery and application services | Process Industries |
